Mutual Fund Ownership
Ownership as on: Fri, 19 Apr, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)12.36
% of AUM4.35%

DSP Midcap Fund Growth

2/5
Equity
Amount Invested (Cr.)646.18
% of AUM4.05%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.39
% of AUM3.87%

Tata India Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)33.63
% of AUM3.83%

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)1.73
% of AUM3.80%

FAQs about Alkem Laboratories share price

Alkem Laboratories is trading at 4597.05 as on Fri Apr 19 2024 09:59:01. This is -1.11% lower as compared to its previous closing price of 4648.75.

The market capitalization of Alkem Laboratories is 54964.63 Cr as on Fri Apr 19 2024 09:59:01.

The average broker rating on Alkem Laboratories is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 6 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 3 analysts have given a sell rating
  • 3 analysts have given a strong sell rating

The 52 wk high for Alkem Laboratories is 5519.10 whereas the 52 wk low is 3211.05

Alkem Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 39.54
  • Sector P/E: 30.14
  • Dividend Yield: 0.97%
  • D/E ratio: -

Alkem Laboratories reported a net profit of 984.17 Cr in 2023.

Recommended For You
Trending Stocks
7,107.00+217.75(3.16%)
2,082.90+58.75(2.90%)
1,531.30+36.70(2.46%)
1,450.00-17.65 (-1.20%)
2,437.10-25.65 (-1.04%)
HomeMarketsPremiumFor youGet App